Ownership

Thomas DiRaimondo

Insider Reports History

Entity: Individual
Location: C/O Janux Therapeutics, Inc., 10955 Vista Sorrento Parkway, Suite 200, San Diego, CA
Signature: /s/ James Pennington, Attorney-in-Fact
All insider transactions: Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Thomas DiRaimondo:

Stock	Role	Class	Num Shares	Value	Price $	Report Date	Ownership
Janux Therapeutics, Inc.	Chief Scientific Officer	Common Stock	130K	$7.44M	$57.37	Jan 2, 2025	Direct
Janux Therapeutics, Inc.	Chief Scientific Officer	Stock option (right to buy)	84K			Jan 2, 2025	Direct

Showing 1 to 2 of 2 entries

Insider Reports Filed by Thomas DiRaimondo

Symbol	Company	Period	Transactions	Value $	Form Type	Date Filed	Role
JANX	Janux Therapeutics, Inc.	Jan 2, 2025	2	$0	4	Jan 3, 2025	Chief Scientific Officer
JANX	Janux Therapeutics, Inc.	Sep 27, 2024	2	-$232K	4	Sep 27, 2024	Chief Scientific Officer
JANX	Janux Therapeutics, Inc.	Jan 2, 2024	1	$0	4	Jan 3, 2024	Chief Scientific Officer
JANX	Janux Therapeutics, Inc.	Jan 1, 2024	0	$0	3	Jan 3, 2024	Chief Scientific Officer